Modulation of venlafaxine partitioning into zwitterionic and charged lipid bilayers via hydrophobic and electrostatic interactions
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The ability of a therapeutic agent to cross lipid membranes is crucial in terms of its pharmacodynamic properties. In this study, the partitioning of venlafaxine, a recently introduced antidepressant in the class of serotonin and norepinephrine reuptake inhibitors (SNRIs), into large unilamellar vesicles (LUVs) composed of zwitterionic 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and negatively charged 1,2-dioleoyl-sn-glycero-3-phosphoglycerol (DOPG) was investigated using second derivative spectrophotometry. The partition coefficients of venlafaxine into DOPC and DOPG LUVs were determined at various temperatures (25, 37, and 45 °C) and pH values (7.4 and 9.5). The results indicate a positive correlation between temperature and the extent of venlafaxine partitioning into both zwitterionic and charged lipid bilayers; furthermore, the drug preferentially partitions into the zwitterionic lipid bilayer at all investigated temperatures. Thermodynamic analysis further reveals that the membrane partitioning of venlafaxine aligns with the classical hydrophobic effect. Varying the proportion of neutral versus charged venlafaxine further indicates that both electrostatic and hydrophobic interactions modulate the partitioning of the drug into the zwitterionic neutral bilayer. In the case of the negatively charged bilayer, electrostatic interactions are predominant over hydrophobic ones in modulating the partitioning of venlafaxine. These findings provide further insights into SNRI–lipid membrane interactions, potentially leading to the development of more effective antidepressants.
Fields of Study & Subjects
Lipid Membrane Structure and Behavior
Drug Solubulity and Delivery Systems
Nanoparticle-Based Drug Delivery
Publication details
- Journal / source
- Science and Technology Development Journal
- Volume
- 29
- Issue
- 1
- Publication date
- 1 January 2026
- Language
- EN